SVRA short interest
Savara Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 43,563,969 |
|---|---|
| Change vs prior report | 220,353 (+0.5%) |
| Change over six months | +58.8% |
| Days to cover | 17.24 (sector: 3.78) |
| Average daily volume | 2,526,580 |
| Rank in Healthcare | #25 of 922 by days to cover |
SVRA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 43,563,969 | +0.5% | 17.24 | 2,526,580 |
| 2026-09-15 | 43,343,616 | +4.6% | 36.25 | 1,195,686 |
| 2026-08-31 | 41,426,996 | +7.6% | 24.32 | 1,703,275 |
| 2026-08-14 | 38,505,948 | +4.6% | 27.12 | 1,419,826 |
| 2026-07-31 | 36,819,551 | +7.8% | 20.13 | 1,829,032 |
| 2026-07-15 | 34,140,223 | +6.6% | 20.82 | 1,639,658 |
| 2026-06-30 | 32,028,140 | +2.1% | 12.64 | 2,534,007 |
| 2026-06-15 | 31,355,322 | +3.9% | 19.29 | 1,625,134 |
| 2026-05-29 | 30,192,189 | +8.2% | 21.81 | 1,384,189 |
| 2026-05-15 | 27,906,370 | +1.0% | 23.86 | 1,169,408 |
| 2026-04-30 | 27,631,844 | -0.1% | 20.89 | 1,322,982 |
| 2026-04-15 | 27,672,077 | +0.9% | 22.87 | 1,209,838 |
| 2026-03-31 | 27,429,578 | +16.7% | 11.36 | 2,415,337 |
| 2026-03-13 | 23,507,787 | +4.9% | 19.89 | 1,181,979 |
| 2026-02-27 | 22,414,290 | +1.2% | 14.90 | 1,504,329 |
| 2026-02-13 | 22,137,744 | +5.6% | 13.93 | 1,589,154 |
| 2026-01-30 | 20,961,935 | -6.1% | 16.29 | 1,286,507 |
| 2026-01-15 | 22,324,237 | -3.1% | 14.18 | 1,574,687 |
| 2025-12-31 | 23,041,562 | +14.2% | 7.11 | 3,242,675 |
| 2025-12-15 | 20,185,493 | +33.1% | 4.75 | 4,247,790 |
| 2025-11-28 | 15,166,976 | -17.5% | 5.70 | 2,660,663 |
| 2025-11-14 | 18,391,645 | +3.4% | 11.64 | 1,579,922 |
| 2025-10-31 | 17,795,876 | +22.5% | 9.19 | 1,937,350 |
| 2025-10-15 | 14,522,734 | +5.5% | 13.84 | 1,049,656 |
| 2025-09-30 | 13,769,978 | -6.9% | 11.49 | 1,197,914 |
import finzdata as yf
yf.Ticker("SVRA").short_interest # every report since 2017
yf.Client().short_interest(["SVRA"], start="2018-01-01")Healthcare short interest · SVRA price history · Who owns SVRA · All short interest